Armistice Capital, LLC Jazz Pharmaceuticals PLC Transaction History

Armistice Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$114.26 - $136.0 $38.7 Million - $46.1 Million	338,882 Added 108.36%	651,626 $80.1 Million
Q3 2023 Nov 14, 2023	SELL	$122.0 - $145.31 $17.5 Million - $20.8 Million	-143,256 Reduced 31.42%	312,744 $40.5 Million
Q2 2023 Aug 14, 2023	BUY	$122.5 - $147.16 $55.9 Million - $67.1 Million	456,000 New	456,000 $56.5 Million
Q2 2022 Aug 15, 2022	SELL	$141.59 - $168.66 $27.5 Million - $32.7 Million	-194,000 Reduced 41.1%	278,000 $43.4 Million
Q1 2022 May 16, 2022	SELL	$129.64 - $160.7 $52.6 Million - $65.2 Million	-406,000 Reduced 46.24%	472,000 $73.5 Million
Q4 2021 Feb 14, 2022	BUY	$119.87 - $145.67 $66.4 Million - $80.7 Million	554,000 Added 170.99%	878,000 $112 Million
Q3 2021 Nov 15, 2021	BUY	$128.64 - $184.79 $41.7 Million - $59.9 Million	324,000 New	324,000 $42.2 Million

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.